Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials Peter Rossing , Silvio E Inzucchi , Priya Vart , Niels Jongs , Kieran F Docherty , Pardeep S Jhund , Lars Køber , Mikhail N Kosiborod , Felipe A Martinez , Piotr Ponikowski , Marc S Sabatine , Scott D Solomon , David L DeMets , Olof Bengtsson , Magnus Lindberg , Anna Maria Langkilde , Mikaela Sjöstrand , Bergur V Stefansson , Cecilia Karlsson , Glenn M Chertow , Fan Fan Hou , Ricardo Correa-Rotter , Robert D Toto , David C Wheeler , John J V McMurray , Hiddo J L Heerspink The Lancet Diabetes & Endocrinology（2022）
AI 理解论文
溯源树
样例
